Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

Biologics are among the most expensive pharmaceuticals ... Perhaps a prime example of a very lengthy monopoly is the arthritis drug Enbrel (etanercept), which was first approved by the FDA ...

The Enbrel biosimilar, which is branded as Erelzi ... that could be spent on newer drugs as well as widening access to biologic medicines. As these medicines are produced in cells instead ...

Maidenhead, UK- The UK National Institute for Health and Clinical Excellence (NICE) has brought out guidance to effectively use biological therapies, Enbrel® (etanercept) and Raptiva ...

protect the human cytomegalovirus promoter—a key regulatory sequence used to increase protein expression and enhance the production of biologic therapeutics. Enbrel, a recombinant fusion protein ...